The Trump administration is losing every legal challenge to its hospital gender-care policies. Seven times — in Colorado, Maryland, Pennsylvania, Washington state — federal judges have quashed or blocked the Department of Justice subpoenas and executive orders targeting institutions that provide gender-affirming care to minors. The administration appealed each one. It lost those too. By any conventional measure of legal strategy, this campaign has produced zero wins. And yet, as Talking Points Memo reported, more than 40 hospitals have already stopped providing gender-affirming care to minors. The policy is working. The courts have nothing to do with it.
Courts Are Blocking Actions the Administration Never Expected to Win
The Justice Department’s subpoenas to hospitals — demanding patient names, dates of birth, addresses, and social security numbers of children who received puberty blockers or hormone therapy — were not serious legal instruments. Judge Julie Rubin in Maryland put it plainly in January 2026, writing that one subpoena “appears to have no purpose other than to intimidate and harass the hospital,” and that “the government seeks to fulfill its policy agenda through compliance born of fear.” Reuters reported her ruling found the DOJ was operating as a deterrence vehicle, not an enforcement one.
The same pattern played out across multiple jurisdictions. Three district courts in Colorado, Maryland, and Pennsylvania quashed subpoenas. Executive orders blocking federal funding were enjoined in two separate preliminary injunctions in Washington state and Maryland, both in early 2025, both citing Fifth Amendment equal protection and separation of powers grounds. The administration appealed everything. The KFF Health Policy tracking analysis found that as of early 2026, no portion of the original executive order’s funding restrictions had survived judicial review long enough to be enforced against any institution.
The Deterrence Is Working While the Courts Are Not
Here is the problem with the “Trump keeps losing in court” framing: it measures the wrong outcome. The administration’s actual goal was never to win in court. The goal was to make providing gender-affirming care feel dangerous enough that hospitals would stop voluntarily — before any case was decided, before any funding was actually pulled, before the legal record clarified what the law actually permitted.
STAT News reported in February 2026 that at least 42 hospitals had paused or ceased offering gender-affirming care to minors, despite proposed CMS rules not being finalised and despite the executive order being largely blocked. By the administration’s own claim, more than 30 hospitals stopped care “in recent weeks” as of late February. Legal experts quoted by AP noted hospitals are making preemptive decisions to avoid being “made the example to enforce the rule on day one.” NYU Langone shuttered its Transgender Youth Health Program entirely — puberty blockers, hormones, surgeries, all of it. So did Children’s Hospital Los Angeles, Children’s Minnesota, and Lurie Children’s in Chicago. None of these institutions were legally required to stop. They stopped because the threat environment made continuing feel like a liability.
This is a remarkable feature of the strategy. The administration is achieving real-world policy outcomes — elimination of services for trans youth across dozens of major medical institutions — without winning a single case. The courts are functioning as intended under a rule-of-law system. The hospitals are responding to something the courts cannot fully address: the cost of being targeted, investigated, and made into a headline, even when you ultimately win.
The Gap Between Legal Theory and Political Reality
Civil rights groups have sued. The ACLU filed suit. New York Attorney General Letitia James warned hospitals that stopping gender-affirming care violates New York state anti-discrimination law, creating a conflicting directive that placed institutions between two legal risks simultaneously. Courts have, by and large, sided with the challengers. None of it has reversed the trend line on hospital closures.
The White House published its position as a policy success. Trump’s executive order targeted hospitals. Hospitals stopped. In the administration’s political accounting, the outcome is what matters, not the mechanism. The fact that the mechanism involved losing in court seven times is, from a communications perspective, entirely beside the point. No hospital that shut down its gender care program will reopen it because a federal judge said the subpoena process was improper. The chilling effect is now structural — it has been built into institutional decision-making regardless of what any appellate court does next.
What This Actually Means
The conventional accountability frame — “Trump lost in court again” — is accurate and insufficient. It describes the legal record without describing the policy outcome. What the 0-for-7 court record actually shows is that the administration has discovered a durable workaround to constitutional limits: use legal process as a tool of deterrence rather than enforcement, absorb the judicial losses, and let the fear do the governing. The courts can block a specific subpoena. They cannot un-ring the bell of institutional risk aversion. In that sense, the administration that keeps losing in court is winning the policy battle it actually came to fight.
Sources
Talking Points Memo | Reuters | STAT News | KFF Health Policy | NBC News | Yahoo News
Background
What is gender-affirming care? Gender-affirming care refers to a range of medical and social interventions — including puberty blockers, hormone therapy, and in some cases surgery — provided to transgender and gender-diverse individuals. For minors, the most common medical interventions are puberty blockers (which delay the physical changes of puberty) and hormone therapy. Major medical organisations including the American Academy of Pediatrics and the American Medical Association support access to gender-affirming care, citing research showing it reduces depression, anxiety, and suicidality in transgender youth.